Dentists in Tryon, NC Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. Delvin Dayle Hornbeck, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 111 New Market Rd, Tryon, NC 28782 Phone: 828-859-9533 |
Dr. Charles W Mccall, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 60 Pacolet St, Tryon, NC 28782 Phone: 828-859-5839 Fax: 828-859-5839 |
Dr. David S Krishingner, DDS Dentist Medicare: Medicare Enrolled Practice Location: 70 Depot St, Tryon, NC 28782 Phone: 828-859-5839 Fax: 828-859-5502 |
Raymond Frederick Meyers, D.M.D Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 289 S Trade St, Tryon, NC 28782 Phone: 828-859-6640 Fax: 828-859-2877 |
Dr. Glenn A Noble, DDS Dentist Medicare: Medicare Enrolled Practice Location: 70 Depot St, Tryon, NC 28782 Phone: 828-859-5839 Fax: 828-858-5502 |
Dr. J Mark Mccall, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 60 Pacolet St, Tryon, NC 28782 Phone: 828-859-5839 Fax: 828-859-5502 |
News Archive
Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
New form of therapy may stop or reverse progressive vision loss
A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness.
Study offers a differentiated patient-specific solution in minimal residual disease testing
Exact Sciences Corp. today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
CBT program to promote alcohol abstinence among HIV-infected people could help save money
Public health research shows that alcohol may be a factor in more than 13 percent of deaths due to infectious diseases, including HIV.
Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
› Verified 9 days ago
Dentists
Counselors
Pharmacists
Clinical Social Workers
Occupational Therapists
Psychologists